文献速递甲状腺疾病

JAK/STAT3与NF-κB信号通路调控未分化甲状腺癌细胞的癌症干细胞特性

JAK/STAT3 and NF-κB Signaling Pathways Regulate Cancer Stem-Cell Properties in Anaplastic Thyroid Cancer Cells.
PubMed 文献 · Thyroid · 2019-03-15

本研究旨在鉴定未分化甲状腺癌(ATC)癌症干细胞(CSC)特有的关键信号通路。采用靶向719种激酶的小干扰RNA文库结合成球实验和细胞存活实验筛选,并用小分子抑制剂在FRO和KTC3细胞及裸鼠移植瘤模型中验证。结果显示JAK/STAT3和NF-κB信号通路对ATC-CSC特性具有重要作用,靶向这些通路可能是治疗ATC的有前景策略。

要点

  • JAK/STAT3和NF-κB信号通路调控未分化甲状腺癌细胞的干细胞特性。
  • PDGFR、JAK、STAT3、PIM和NF-κB抑制剂均剂量依赖性抑制成球但不影响常规生长。
  • 抑制JAK/STAT3和NF-κB通路可减少软琼脂非锚定生长和裸鼠肿瘤生长。

核心结论

  • JAK/STAT3和NF-κB信号在未分化甲状腺癌癌症干细胞中起重要作用,靶向这些通路可能是有前景的治疗方法。

研究设计与样本

  • 基础研究:使用靶向719种激酶的小干扰RNA文库,在未分化甲状腺癌细胞系中进行成球实验和细胞存活实验筛选。
  • 用小分子抑制剂在FRO和KTC3细胞中通过成球、细胞存活、软琼脂和裸鼠移植瘤实验验证候选分子功能。

主要发现

  • PDGFR、JAK和PIM的小干扰RNA在FRO和KTC3细胞中对成球有较高抑制效果,对常规细胞生长抑制较低或无抑制。
  • PDGFR、JAK、STAT3、PIM和NF-κB抑制剂均剂量依赖性抑制成球,但不抑制常规细胞生长。
  • 抑制JAK/STAT3和NF-κB通路减少软琼脂中非锚定生长和裸鼠肿瘤生长。

临床怎么用

  • 靶向JAK/STAT3和NF-κB信号通路可能为未分化甲状腺癌提供新的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Anaplastic thyroid carcinoma (ATC) is one of the most aggressive and refractory cancers, and a therapy with a new concept needs to be developed. Recently, research on cancer stem cells (CSCs) has progressed, and CSCs have been suggested to be responsible for metastasis, recurrence, and therapy resistance. In ATC-CSCs, aldehyde dehydrogenase (ALDH) activity is the most reliable marker to enrich CSCs. However, it is just a marker and is not involved in CSC properties. The present study therefore aimed to identify key signaling pathways specific for ATC-CSCs. Methods: A small interfering RNA library targeting 719 kinases was used in a sphere formation assay and cell survival assay using ATC cell lines to select target molecules specific for CSC properties. The functions of the selected candidates were confirmed by sphere formation, cell survival, soft agar, and nude mice xenograft assays using small compound inhibitors. Results: The study focused on PDGFR, JAK, and PIM, whose small interfering RNAs had a higher inhibitory effect on sphere formation, as well as a lower or no effect on regular cell growth in both FRO and KTC3 cells. Next, inhibitors of PDGFR, JAK, STAT3, PIM and NF-κB were used, and all of them successfully suppressed sphere formation in a dose-dependent manner but not regular cell growth, confirming the screening results. Inhibition of the JAK/STAT3 and NF-κB pathways also reduced anchorage-independent growth in soft agar and tumor growth in nude mice. Conclusions: These results suggest that JAK/STAT3 and NF-κB signals play important roles in ATC-CSCs. Targeting these signaling pathways may be a promising approach to treat ATC.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Shiraiwa K, Matsuse M, Nakazawa Y, et al. JAK/STAT3 and NF-κB Signaling Pathways Regulate Cancer Stem-Cell Properties in Anaplastic Thyroid Cancer Cells. Thyroid. 2019. PMID: 30784360. doi:10.1089/thy.2018.0212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。